These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10707743)

  • 21. Impact of placebo assignment in clinical trials of Parkinson's disease.
    Goetz CG; Janko K; Blasucci L; Jaglin JA
    Mov Disord; 2003 Oct; 18(10):1146-9. PubMed ID: 14534918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Roaming through methodology. IV. Causality].
    van Gijn J; Rooijmans HG
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1765-7. PubMed ID: 9856141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials.
    Brinkhaus B; Pach D; Lüdtke R; Willich SN
    Contemp Clin Trials; 2008 Mar; 29(2):149-56. PubMed ID: 17669693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Knipschild PG
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1826-8. PubMed ID: 11020835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [How to improve the quality of clinical trials].
    Galende I; Sacristán JA; Soto J
    Med Clin (Barc); 1994 Apr; 102(12):465-70. PubMed ID: 8207997
    [No Abstract]   [Full Text] [Related]  

  • 26. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The placebo problem].
    Reinhard W
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():35S-39S. PubMed ID: 7321658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placebo misconceptions.
    Senn S
    Am J Bioeth; 2009 Sep; 9(9):53-4. PubMed ID: 19998195
    [No Abstract]   [Full Text] [Related]  

  • 30. Is homeopathy a clinically valuable approach?
    Ernst E
    Trends Pharmacol Sci; 2005 Nov; 26(11):547-8. PubMed ID: 16165225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-placebo difference: in antidepressant drug trials could be 50% greater than previously believed.
    Rihmer Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):35-7. PubMed ID: 17879563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roaming through methodology. XXXVI. Likelihood ratios and Bayes' rule].
    Vermeulen M
    Ned Tijdschr Geneeskd; 2001 Dec; 145(50):2421-4. PubMed ID: 11776667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo: new insights into an old enigma.
    Ernst E
    Drug Discov Today; 2007 May; 12(9-10):413-8. PubMed ID: 17467578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Placebo, placebo effect and clinical trials].
    de la Fuente-Fernández R
    Neurologia; 2007 Mar; 22(2):69-71. PubMed ID: 17323230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
    D'Haens G; Sandborn WJ; Feagan BG; Geboes K; Hanauer SB; Irvine EJ; Lémann M; Marteau P; Rutgeerts P; Schölmerich J; Sutherland LR
    Gastroenterology; 2007 Feb; 132(2):763-86. PubMed ID: 17258735
    [No Abstract]   [Full Text] [Related]  

  • 36. Methodological issues and complementary therapies: researching intangibles?
    Carter B
    Complement Ther Nurs Midwifery; 2003 Aug; 9(3):133-9. PubMed ID: 12852929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sensible use of placebo in psychopharmacological research].
    Kotler M; Witztum E
    Harefuah; 1999 May; 136(9):692-4. PubMed ID: 10955091
    [No Abstract]   [Full Text] [Related]  

  • 38. Reducing exposure of clinical research subjects to placebo treatments.
    Noble RE; Gelfand LA; DeRubeis RJ
    J Clin Psychol; 2005 Jul; 61(7):881-92. PubMed ID: 15827998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving efficiency of ALS clinical trials using lead-in designs.
    Moore DH; Miller RG
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.